Showing results (341-350 of 1,854) with videos related to

Sort By:
Pageof 186
JAMA Ophthalmology|September 12, 2012
Primary open-angle glaucoma vs normal-tension glaucoma: the vascular perspectiveStephanie Mroczkowska, Alexandra Benavente-Perez, Anil Negi, et al.
JAMA Ophthalmology|August 21, 2020
Association of Sex With Frequent and Mild ABCA4 Alleles in Stargardt DiseaseEsmee H Runhart, Mubeen Khan, Stéphanie S Cornelis, et al.
JAMA Ophthalmology|August 21, 2020
Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti-Vascular Endothelial Growth Factor AgentsRebecca N Evans, Barnaby C Reeves, Maureen G Maguire, et al.
JAMA Ophthalmology|March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical TrialRaj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA Ophthalmology|August 14, 2020
Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular DegenerationMaximilian Pfau, Leon von der Emde, Luis de Sisternes, et al.
JAMA Ophthalmology|March 6, 2015
Expression of concern: Thakur A, Kadam R, Kompella UB. Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts. Arch Ophthalmol. 2011:129(7):914-920Neil M Bressler, Howard Bauchner
JAMA Ophthalmology|February 6, 2015
Assessment of online patient education materials from major ophthalmologic associationsGrace Huang, Christina H Fang, Nitin Agarwal, et al.
JAMA Ophthalmology|March 13, 2015
Reticular pseudodrusen associated with a diseased bruch membrane in pseudoxanthoma elasticumMartin Gliem, Doris Hendig, Robert P Finger, et al.
JAMA Ophthalmology|May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trialsGui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
JAMA Ophthalmology|January 25, 2014
Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trialRajeshwari D Koilkonda, Hong Yu, Tsung-Han Chou, et al.
Pageof 186